Skip to main content
Figure 1 | Journal of Neuroinflammation

Figure 1

From: Absence of IL-1β positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury

Figure 1

Dose-dependent mortality after spinal cord compression injury. The mortality rate in mice with local administration of recombinant IL-1β (rIL-1β) in Gelfoam directly after spinal cord compression injury (SCI) was 100% in mice treated with 20 μg rIL-1β, and was significantly higher compared with mice treated with 1 μg rIL-1β or only with PBS. P <0.0001 using the log-rank test.

Back to article page